Anavex Life Sciences Corp. (AVXL)

3.80 +0.15 (+4.11%) USD  |  NASDAQ  |  Dec 30, 16:00
3.79 -0.01 (-0.26%) Pre-Market: 20:00
More

Anavex Life Sciences EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for AVXL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
CorMedix, Inc. Upgrade
Verastem, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Aldeyra Therapeutics, Inc. Upgrade